These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 26538208)

  • 1. Efficacy of Mirtazapine in Patients With Functional Dyspepsia and Weight Loss.
    Tack J; Ly HG; Carbone F; Vanheel H; Vanuytsel T; Holvoet L; Boeckxstaens G; Caenepeel P; Arts J; Van Oudenhove L
    Clin Gastroenterol Hepatol; 2016 Mar; 14(3):385-392.e4. PubMed ID: 26538208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of buspirone, a fundus-relaxing drug, in patients with functional dyspepsia.
    Tack J; Janssen P; Masaoka T; Farré R; Van Oudenhove L
    Clin Gastroenterol Hepatol; 2012 Nov; 10(11):1239-45. PubMed ID: 22813445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of short-term, low-dose tricyclic and tetracyclic antidepressant treatment on satiation, postnutrient load gastrointestinal symptoms and gastric emptying: a double-blind, randomized, placebo-controlled trial.
    Choung RS; Cremonini F; Thapa P; Zinsmeister AR; Talley NJ
    Neurogastroenterol Motil; 2008 Mar; 20(3):220-7. PubMed ID: 18031471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of mirtazapine on gastric accommodation, gastric sensitivity to distention, and nutrient tolerance in healthy subjects.
    Carbone F; Vanuytsel T; Tack J
    Neurogastroenterol Motil; 2017 Dec; 29(12):. PubMed ID: 28695632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial effects of antidepressant mirtazapine in functional dyspepsia patients with weight loss.
    Jiang SM; Jia L; Liu J; Shi MM; Xu MZ
    World J Gastroenterol; 2016 Jun; 22(22):5260-6. PubMed ID: 27298569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind placebo controlled study of acotiamide hydrochloride for efficacy on gastrointestinal motility of patients with functional dyspepsia.
    Nakamura K; Tomita T; Oshima T; Asano H; Yamasaki T; Okugawa T; Kondo T; Kono T; Tozawa K; Ohda Y; Fukui H; Kazuhito F; Hirota S; Watari J; Miwa H
    J Gastroenterol; 2017 May; 52(5):602-610. PubMed ID: 27639387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy and Safety of New Prokinetic Agent Benachio Q Solution® in Patients with Postprandial Distress Syndrome Subtype in Functional Dyspepsia: A Single-center, Randomized, Double-blind, Placebo-controlled Pilot Study].
    Shim YK; Lee JY; Kim NY; Park YH; Yoon H; Shin CM; Park YS; Lee DH
    Korean J Gastroenterol; 2015 Jul; 66(1):17-26. PubMed ID: 26194125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A dose-ranging, placebo-controlled, pilot trial of Acotiamide in patients with functional dyspepsia.
    Tack J; Masclee A; Heading R; Berstad A; Piessevaux H; Popiela T; Vandenberghe A; Kato H
    Neurogastroenterol Motil; 2009 Mar; 21(3):272-80. PubMed ID: 19254354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Amitriptyline and Escitalopram on Functional Dyspepsia: A Multicenter, Randomized Controlled Study.
    Talley NJ; Locke GR; Saito YA; Almazar AE; Bouras EP; Howden CW; Lacy BE; DiBaise JK; Prather CM; Abraham BP; El-Serag HB; Moayyedi P; Herrick LM; Szarka LA; Camilleri M; Hamilton FA; Schleck CD; Tilkes KE; Zinsmeister AR
    Gastroenterology; 2015 Aug; 149(2):340-9.e2. PubMed ID: 25921377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of liraglutide on weight, satiation, and gastric functions in obesity: a randomised, placebo-controlled pilot trial.
    Halawi H; Khemani D; Eckert D; O'Neill J; Kadouh H; Grothe K; Clark MM; Burton DD; Vella A; Acosta A; Zinsmeister AR; Camilleri M
    Lancet Gastroenterol Hepatol; 2017 Dec; 2(12):890-899. PubMed ID: 28958851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A placebo-controlled trial of the 5-HT1A agonist R-137696 on symptoms, visceral hypersensitivity and on impaired accommodation in functional dyspepsia.
    Tack J; Van Den Elzen B; Tytgat G; Wajs E; Van Nueten L; De Ridder F; Boeckxstaens G
    Neurogastroenterol Motil; 2009 Jun; 21(6):619-26, e23-4. PubMed ID: 19220756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A meta-analysis of eight randomized, double-blind, controlled clinical trials of mirtazapine for the treatment of patients with major depression and symptoms of anxiety.
    Fawcett J; Barkin RL
    J Clin Psychiatry; 1998 Mar; 59(3):123-7. PubMed ID: 9541155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the antidepressant venlafaxine in functional dyspepsia: a randomized, double-blind, placebo-controlled trial.
    van Kerkhoven LA; Laheij RJ; Aparicio N; De Boer WA; Van den Hazel S; Tan AC; Witteman BJ; Jansen JB
    Clin Gastroenterol Hepatol; 2008 Jul; 6(7):746-52; quiz 718. PubMed ID: 18424191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Chaihu-Shugan-San on functional dyspepsia and gut microbiota: A randomized, double-blind, placebo-controlled trial.
    Wang Y; Jia Y; Liu X; Yang K; Lin Y; Shao Q; Ling J
    J Ethnopharmacol; 2024 Mar; 322():117659. PubMed ID: 38151181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose mirtazapine: a new option in the treatment of antipsychotic-induced akathisia. A randomized, double-blind, placebo- and propranolol-controlled trial.
    Poyurovsky M; Pashinian A; Weizman R; Fuchs C; Weizman A
    Biol Psychiatry; 2006 Jun; 59(11):1071-7. PubMed ID: 16497273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secretin effects on gastric functions, hormones and symptoms in functional dyspepsia and health: randomized crossover trial.
    Brandler J; Miller LJ; Wang XJ; Burton D; Busciglio I; Arndt K; Harmsen WS; Camilleri M
    Am J Physiol Gastrointest Liver Physiol; 2020 Apr; 318(4):G635-G645. PubMed ID: 32036693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A traditional herbal formula, Hyangsa-Pyeongwi san (HPS), improves quality of life (QoL) of the patient with functional dyspepsia (FD): randomized double-blinded controlled trial.
    Kim JB; Shin JW; Kang JY; Son CG; Kang W; Lee HW; Lee DS; Park YC; Cho JH
    J Ethnopharmacol; 2014; 151(1):279-86. PubMed ID: 24239600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional Dyspepsia Treatment Trial (FDTT): a double-blind, randomized, placebo-controlled trial of antidepressants in functional dyspepsia, evaluating symptoms, psychopathology, pathophysiology and pharmacogenetics.
    Talley NJ; Locke GR; Herrick LM; Silvernail VM; Prather CM; Lacy BE; DiBaise JK; Howden CW; Brenner DM; Bouras EP; El-Serag HB; Abraham BP; Moayyedi P; Zinsmeister AR
    Contemp Clin Trials; 2012 May; 33(3):523-33. PubMed ID: 22343090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized clinical trial: rikkunshito in the treatment of functional dyspepsia--a multicenter, double-blind, randomized, placebo-controlled study.
    Suzuki H; Matsuzaki J; Fukushima Y; Suzaki F; Kasugai K; Nishizawa T; Naito Y; Hayakawa T; Kamiya T; Andoh T; Yoshida H; Tokura Y; Nagata H; Kobayakawa M; Mori M; Kato K; Hosoda H; Takebayashi T; Miura S; Uemura N; Joh T; Hibi T; Tack J;
    Neurogastroenterol Motil; 2014 Jul; 26(7):950-61. PubMed ID: 24766295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Itopride in functional dyspepsia: results of two phase III multicentre, randomised, double-blind, placebo-controlled trials.
    Talley NJ; Tack J; Ptak T; Gupta R; Giguère M
    Gut; 2008 Jun; 57(6):740-6. PubMed ID: 17965059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.